Trial Profile
A single-center prospective Study of apixaban in patients with nonvalvular paroxysmal or chronic atrial brillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Feb 2019
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 26 Sep 2018 New trial record